| Bioactivity | WAY-151932 is a vasopressin V2-receptor agonist with IC50 of 80.3 nM and 778 nM in human-V2 binding and V1a binding assay. | ||||||||||||
| Target | IC50: 80.3 nM (human-V2 binding), 778 nM (human-V1a binding) | ||||||||||||
| Invitro | WAY-151932 (VNA-932) stimulates cAMP formation in LV2 cells expressing the hV2 receptors in a dose-dependent manner with an EC50 of 0.74±0.07 nM[2]. | ||||||||||||
| In Vivo | Oral administration of WAY-151932 (VNA-932) to water-loaded conscious rats produces a dose-dependent decrease in urine volume (ED50=0.14 mg/kg, 2.5% starch in water vehicle) and a corresponding increase in osmolality without altering the urine electrolyte excretion profile[2]. | ||||||||||||
| Name | WAY-151932 | ||||||||||||
| CAS | 220460-92-4 | ||||||||||||
| Formula | C23H19ClN4O | ||||||||||||
| Molar Mass | 402.88 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Molinari AJ, et al. Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5796-800. [2]. Failli AA, et al. Pyridobenzodiazepines: a novel class of orally active, vasopressin V2 receptor selective agonists. Bioorg Med Chem Lett. 2006 Feb 15;16(4):954-9. |
WAY-151932
CAS: 220460-92-4 F: C23H19ClN4O W: 402.88
WAY-151932 is a vasopressin V2-receptor agonist with IC50 of 80.3 nM and 778 nM in human-V2 binding and V1a binding assa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.